Cencora (COR) Net Profit Margin: History & Chart

Cencora, Inc.(COR)

Medical - Distribution · Conshohocken, PA

$321.57+0.62 (+0.19%)

Delayed quote: Sep 11, 2026, 4:00 PM EDT

About Cencora, Inc.

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.

Conshohocken, PA

49,000 employees

www.cencora.com

Healthcare / Medical - Distribution

Sector: Healthcare
Industry: Medical - Distribution
CEO: Robert Mauch

View full financials

COR Net Profit Margin Metrics

NET PROFIT MARGIN

0.79%

NET PROFIT MARGIN AVG TTM

0.82%

NET PROFIT MARGIN AVG 3Y

0.73%

NET PROFIT MARGIN AVG 5Y

0.72%

NET PROFIT MARGIN AVG 10Y

0.64%

NET PROFIT MARGIN AVG 15Y

0.64%

NET PROFIT MARGIN AVG 20Y

0.70%

CURRENT VS TTM AVG

-3.50%

CURRENT VS 3Y AVG

+8.53%

CURRENT VS 5Y AVG

+10.40%

CURRENT VS 10Y AVG

+22.91%

CURRENT VS 15Y AVG

+23.60%

CURRENT VS 20Y AVG

+12.82%

SECTOR MEDIAN · HEALTHCARE

9.21%

median of 90 covered companies

CURRENT VS SECTOR MEDIAN

-91.42%

vs the sector median at left

NAME	MARKET CAP	NET PROFIT MARGIN	TTM	3Y	5Y
Cencora, Inc. (COR)	$62.57B	0.79%	0.82%	0.73%	0.72%
Boston Scientific Corporation (BSX)vs ›	$63.88B	17.47%	12.73%	10.54%	8.34%
Moderna, Inc. (MRNA)vs ›	$57.13B	-141.43%	-128.24%	-70.25%	-50.87%
Cardinal Health, Inc. (CAH)vs ›	$54.94B	0.67%	0.69%	0.48%	0.29%
Cigna Corporation (CI)vs ›	$74.19B	2.27%	1.78%	2.48%	3.04%
Humana Inc. (HUM)vs ›	$49.21B	0.88%	0.97%	1.82%	2.53%
Becton, Dickinson and Company (BDX)vs ›	$49.00B	4.52%	8.06%	8.30%	8.27%
Edwards Lifesciences Corporation (EW)vs ›	$48.58B	15.43%	47.22%	37.68%	33.03%
Regeneron Pharmaceuticals, Inc. (REGN)vs ›	$80.51B	27.86%	31.24%	32.06%	36.64%
Teva Pharmaceutical Industries Limited (TEVA)vs ›	$43.20B	4.08%	-0.87%	-5.42%	-7.16%

NAME

MARKET CAP

NET PROFIT MARGIN

TTM

Cencora, Inc. (COR)

$62.57B

0.79%

0.82%

0.73%

0.72%

Boston Scientific Corporation (BSX)vs ›

$63.88B

17.47%

12.73%

10.54%

8.34%

Moderna, Inc. (MRNA)vs ›

$57.13B

-141.43%

-128.24%

-70.25%

-50.87%

Cardinal Health, Inc. (CAH)vs ›

$54.94B

0.67%

0.69%

0.48%

0.29%

Cigna Corporation (CI)vs ›

$74.19B

2.27%

1.78%

2.48%

3.04%

Humana Inc. (HUM)vs ›

$49.21B

0.88%

0.97%

1.82%

2.53%

Becton, Dickinson and Company (BDX)vs ›

$49.00B

4.52%

8.06%

8.30%

8.27%

Edwards Lifesciences Corporation (EW)vs ›

$48.58B

15.43%

47.22%

37.68%

33.03%

Regeneron Pharmaceuticals, Inc. (REGN)vs ›

$80.51B

27.86%

31.24%

32.06%

36.64%

Teva Pharmaceutical Industries Limited (TEVA)vs ›

$43.20B

4.08%

-0.87%

-5.42%

-7.16%

Net Profit Margin FAQ

What is the net profit margin for Cencora, Inc. (COR)?

The net profit margin for COR stock is 0.79%.

Is Cencora, Inc.'s net profit margin high or low?

The net profit margin of 0.79% is 10% above its 5-year average of 0.72%, around the middle of its 5-year range (-0.41%–2.09%).

What is the TTM average net profit margin for Cencora, Inc. (COR)?

The TTM average net profit margin for COR stock is 0.82%.

What is the 3Y average net profit margin for Cencora, Inc. (COR)?

The 3Y average net profit margin for COR stock is 0.73%.

What is the 5Y average net profit margin for Cencora, Inc. (COR)?

The 5Y average net profit margin for COR stock is 0.72%.

What is the 10Y average net profit margin for Cencora, Inc. (COR)?

The 10Y average net profit margin for COR stock is 0.64%.

What is the 15Y average net profit margin for Cencora, Inc. (COR)?

The 15Y average net profit margin for COR stock is 0.64%.

What is the 20Y average net profit margin for Cencora, Inc. (COR)?

The 20Y average net profit margin for COR stock is 0.70%.

DATE	NET PROFIT MARGIN
2026-06-30	0.90%
2026-03-31	2.09%
2025-12-31	0.65%
2025-09-30	-0.41%
2025-06-30	0.85%
2025-03-31	0.95%
2024-12-31	0.60%
2024-09-30	0.00%
2024-06-30	0.65%
2024-03-31	0.62%
2023-12-31	0.83%
2023-09-30	0.51%
2023-06-30	0.72%
2023-03-31	0.69%
2022-12-31	0.76%
2022-09-30	0.48%
2022-06-30	0.68%
2022-03-31	0.95%
2021-12-31	0.75%
2021-09-30	0.74%
2021-06-30	0.55%
2021-03-31	0.89%
2020-12-31	0.71%
2020-09-30	-9.84%
2020-06-30	0.64%
2020-03-31	2.03%
2019-12-31	0.39%
2019-09-30	0.29%
2019-06-30	0.67%
2019-03-31	0.06%
2018-12-31	0.87%
2018-09-30	0.54%
2018-06-30	0.64%
2018-03-31	0.70%
2017-12-31	2.13%
2017-09-30	-0.75%
2017-06-30	0.13%
2017-03-31	1.11%
2016-12-31	0.65%
2016-09-30	0.38%
2016-06-30	0.95%
2016-03-31	1.69%
2015-12-31	0.90%
2015-09-30	1.03%
2015-06-30	0.63%
2015-03-31	-1.57%
2014-12-31	-0.60%
2014-09-30	0.21%
2014-06-30	-0.04%
2014-03-31	0.63%
2013-12-31	0.14%
2013-09-30	0.21%
2013-06-30	0.77%
2013-03-31	0.22%
2012-12-31	0.79%
2012-09-30	0.85%
2012-06-30	0.92%
2012-03-31	1.06%
2011-12-31	0.80%
2011-09-30	0.72%
2011-06-30	0.91%
2011-03-31	1.08%
2010-12-31	0.81%
2010-09-30	0.72%
2010-06-30	0.83%
2010-03-31	0.94%
2009-12-31	0.78%
2009-09-30	0.70%
2009-06-30	0.65%
2009-03-31	0.83%
2008-12-31	0.64%
2008-09-30	0.67%
2008-06-30	-0.60%
2008-03-31	0.75%
2007-12-31	0.63%
2007-09-30	0.53%
2007-06-30	0.79%
2007-03-31	0.78%
2006-12-31	0.73%
2006-09-30	0.78%
2006-06-30	0.76%
2006-03-31	0.85%
2005-12-31	0.67%
2005-09-30	0.53%
2005-06-30	0.69%
2005-03-31	0.75%
2004-12-31	0.47%
2004-09-30	0.69%
2004-06-30	0.96%
2004-03-31	1.06%
2003-12-31	0.81%
2003-09-30	0.95%
2003-06-30	0.91%
2003-03-31	0.96%
2002-12-31	0.75%
2002-09-30	0.82%

DATE

NET PROFIT MARGIN

2026-06-30

0.90%

2026-03-31

2.09%

2025-12-31

0.65%

2025-09-30

-0.41%

2025-06-30

0.85%

2025-03-31

0.95%

2024-12-31

0.60%

2024-09-30

0.00%

2024-06-30

0.65%

2024-03-31

0.62%

2023-12-31

0.83%

2023-09-30

0.51%

2023-06-30

0.72%

2023-03-31

0.69%

2022-12-31

0.76%

2022-09-30

0.48%

2022-06-30

0.68%

2022-03-31

0.95%

2021-12-31

0.75%

2021-09-30

0.74%

2021-06-30

0.55%

2021-03-31

0.89%

2020-12-31

0.71%

2020-09-30

-9.84%

2020-06-30

0.64%

2020-03-31

2.03%

2019-12-31

0.39%

2019-09-30

0.29%

2019-06-30

0.67%

2019-03-31

0.06%

2018-12-31

0.87%

2018-09-30

0.54%

2018-06-30

0.64%

2018-03-31

0.70%

2017-12-31

2.13%

2017-09-30

-0.75%

2017-06-30

0.13%

2017-03-31

1.11%

2016-12-31

0.65%

2016-09-30

0.38%

2016-06-30

0.95%

2016-03-31

1.69%

2015-12-31

0.90%

2015-09-30

1.03%

2015-06-30

0.63%

2015-03-31

-1.57%

2014-12-31

-0.60%

2014-09-30

0.21%

2014-06-30

-0.04%

2014-03-31

0.63%

2013-12-31

0.14%

2013-09-30

0.21%

2013-06-30

0.77%

2013-03-31

0.22%

2012-12-31

0.79%

2012-09-30

0.85%

2012-06-30

0.92%

2012-03-31

1.06%

2011-12-31

0.80%

2011-09-30

0.72%

2011-06-30

0.91%

2011-03-31

1.08%

2010-12-31

0.81%

2010-09-30

0.72%

2010-06-30

0.83%

2010-03-31

0.94%

2009-12-31

0.78%

2009-09-30

0.70%

2009-06-30

0.65%

2009-03-31

0.83%

2008-12-31

0.64%

2008-09-30

0.67%

2008-06-30

-0.60%

2008-03-31

0.75%

2007-12-31

0.63%

2007-09-30

0.53%

2007-06-30

0.79%

2007-03-31

0.78%

2006-12-31

0.73%

2006-09-30

0.78%

2006-06-30

0.76%

2006-03-31

0.85%

2005-12-31

0.67%

2005-09-30

0.53%

2005-06-30

0.69%

2005-03-31

0.75%

2004-12-31

0.47%

2004-09-30

0.69%

2004-06-30

0.96%

2004-03-31

1.06%

2003-12-31

0.81%

2003-09-30

0.95%

2003-06-30

0.91%

2003-03-31

0.96%

2002-12-31

0.75%

2002-09-30

0.82%

Net Profit Margin: 0.79%

COR Profit Margin

COR Average Net Profit Margin Chart

COR Current vs Average Net Profit Margin Chart

COR Net Profit Margin Metrics

COR Competitors' Net Profit Margin

Margin Comparison

Net Profit Margin Formula & Definition

Net Profit Margin FAQ

COR Net Profit Margin History

Related Metrics